Belgium· BE-AMP-SAM445103-00
Valdispert Sleep
A medicinal product containing valeriana officinalis l., root, dry extract, ethanol, 70, 3-6_1, registered in Belgium by Vemedia Manufacturing.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Valeriana officinalis L., Root, Dry Extract, Ethanol, 70, 3-6_1
- Manufacturer
- Vemedia Manufacturing
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3020906
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c56f6f5e-177f-4b1d-aee2-5d6847b19229 GET /v1/drugs/c56f6f5e-177f-4b1d-aee2-5d6847b19229?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Valdispert Sleep",
"name_fr": "Valdispert Sleep",
"name_nl": "Valdispert Sleep",
"amp_code": "SAM445103-00",
"strengths": [
"125.0000",
"250.0000"
],
"pack_count": 5,
"substances": [
"Valeriana officinalis L., Root, Dry Extract, Ethanol, 70, 3-6_1",
"Passiflora incarnata L., Herb, Dry Extract, EtOH, 50, 5-7_1"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": [
"BE-TU445103"
]
}See everything about valeriana officinalis l., root, dry extract, ethanol, 70, 3-6_1.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.